Related Experiment Video
Updated: Feb 11, 2026

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury
Published on: February 10, 2020
Ketamine ameliorates oxidative stress-induced apoptosis in experimental traumatic brain injury via the Nrf2 pathway
Jinwei Liang1, Shanhu Wu1, Wenxi Xie1
1Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, People's Republic of China.
Background:
Ketamine can act as a multifunctional neuroprotective agent by inhibiting oxidative stress, cellular dysfunction, and apoptosis. Although it has been proven to be effective in various neurologic disorders, the mechanism of the treatment of traumatic brain injury (TBI) is not fully understood. The aim of this study was to investigate the neuroprotective function of ketamine in models of TBI and the potential role of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in this putative protective effect.
Materials And Methods:
Wild-type male mice were randomly assigned to five groups: Sham group, Sham + ketamine group, TBI group, TBI + vehicle group, and TBI + ketamine group. Marmarou's weight drop model in mice was used to induce TBI, after which either ketamine or vehicle was administered via intraperitoneal injection. After 24 h, the brain samples were collected for analysis.
Results:
Ketamine significantly ameliorated secondary brain injury induced by TBI, including neurological deficits, brain water content, and neuronal apoptosis. In addition, the levels of malondialdehyde (MDA), glutathione peroxidase (GPx), and superoxide dismutase (SOD) were restored by the ketamine treatment. Western blotting and immunohistochemistry showed that ketamine significantly increased the level of Nrf2. Furthermore, administration of ketamine also induced the expression of Nrf2 pathway-related downstream factors, including hemeoxygenase-1 and quinine oxidoreductase-1, at the pre- and post-transcriptional levels.
Conclusion:
Ketamine exhibits neuroprotective effects by attenuating oxidative stress and apoptosis after TBI. Therefore, ketamine could be an effective therapeutic agent for the treatment of TBI.
Insights
Ketamine demonstrates neuroprotective effects against traumatic brain injury (TBI) by reducing oxidative stress and apoptosis. This study highlights ketamine
Area of Science:
- Neuroscience
- Pharmacology
- Cellular Biology
Background:
- Ketamine is a known neuroprotective agent, but its mechanism in treating traumatic brain injury (TBI) requires further elucidation.
- Oxidative stress, cellular dysfunction, and apoptosis are key pathological features of TBI.
Purpose of the Study:
- To investigate the neuroprotective effects of ketamine in TBI models.
- To explore the role of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in ketamine's TBI treatment mechanism.
Main Methods:
- A weight drop model was used to induce TBI in male wild-type mice.
- Mice were divided into sham, TBI, and TBI + ketamine/vehicle groups, with ketamine administered via intraperitoneal injection.
- Brain tissue was collected 24 hours post-injury for analysis.
Main Results:
- Ketamine treatment significantly reduced neurological deficits, brain water content, and neuronal apoptosis in TBI mice.
- Ketamine administration restored levels of oxidative stress markers (MDA, GPx, SOD) and increased Nrf2 protein expression.
- The expression of Nrf2 downstream targets (hemeoxygenase-1, quinine oxidoreductase-1) was upregulated by ketamine.
Conclusions:
- Ketamine effectively attenuates oxidative stress and apoptosis, thereby exerting neuroprotective effects post-TBI.
- Ketamine shows potential as a therapeutic agent for treating traumatic brain injury.
Related Concept Videos
Post-traumatic Stress Disorder
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
Nitric Oxide Signaling Pathway
Apoptosis
Oxidation Numbers
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...

